NOVELION THERAPEUTICS INC - COM NEW (NVLNF)

CUSIP: 67001K202

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class
Equity / COM NEW
Total 13F shares
6,857,145
Share change
-185,490
Total reported value
$5,347,212
Price per share
$0.78
Number of holders
22
Value change
-$744,740
Number of buys
10
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 67001K202?
CUSIP 67001K202 identifies NVLNF - NOVELION THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NOVELION THERAPEUTICS INC - COM NEW (NVLNF) as of Q2 2019

As of 30 Jun 2019, NOVELION THERAPEUTICS INC - COM NEW (NVLNF) was held by 22 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,857,145 shares. The largest 10 holders included EdgePoint Investment Group Inc., Healthcare Value Capital, LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, Stonepine Capital Management, LLC, GOLDMAN SACHS GROUP INC, Knott David M, CITADEL ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, GROUP ONE TRADING, L.P., and FRANKLIN STREET ADVISORS INC /NC. This page lists 22 institutional shareholders reporting positions in this security for the Q2 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.